Fighting for Breath: How the FDA’s Lax Generic Drug Rules Put Her Life at Risk

ProPublica

09 January 2026

Lung transplant patient Hannah Goetz’s life depended on the generic version of a critical drug. It was supposed to be equivalent to the brand-name medication — but the FDA doesn’t always ensure that’s the case. By Megan Rose and Debbie Cenziper. Originally published Dec. 19, 2025. Recorded by News Over Audio. Support our journalism by donating at propublica.org/donate.